Clinical Trial

Real World Assessment of People Living With Chronic Hepatitis B in Australia

Study acronym: REACH-B
Recruiting
View on ClinicalTrials.gov →
Summary
The REACH-B study establishes an observational cohort study of people living with chronic hepatitis B from a national network, including a diverse range of services, to characterise and monitor hepatitis B linkage to care and treatment requirements amongst this population.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-05-30; most recent amendment 2026-05-18.
Status change: Not Yet Recruiting → Recruiting 2022-02-20
Trial Details
NCT Number NCT04914611
Lead Sponsor Kirby Institute
Conditions Hepatitis B
Enrollment 10,000 participants
Start Date 2022-02-17
Primary Completion 2030-07-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-19